New York Met Robinson Cano tested positive for the performance-enhancing drug Stanozolol, and he will be suspended for the 2021 season (162 games).
Mets President Sandy Alderson released a statement supporting the suspension.
We were extremely disappointed to be informed about Robinson’s suspension for violating Major League Baseball’s Joint Drug Prevention and Treatment Program. The violation is very unfortunate for him, the organization, our fans, and the sport. The Mets fully support MLB’s efforts toward eliminating performance enhancing substances from the game.
Stanozolol is a performance-enhancing anabolic androgenic steroid (AAS), used to improve physical appearance and performance.
Some side effects associated with stanozolol are impotence, testicular atrophy, prostatic hypertrophy in men, and menstrual irregularities, acne, atrophy of the breasts in women.
Cano is no stranger to failing PED test, in 2018 he was suspended 80 games for testing positive for a diuretic.
Since Cano tested positive twice for PEDs he is automatically suspended for a full season, according to the joint drug agreement between Major League Baseball and the MLB Players Association.
Cano will lose $24 million due to his suspension, but he is in the eighth year of a 10-year $240 million contract. He is owed $48 million over the next two years.
Money issues are definitely not a problem for Cano.
Hopefully, Robinson Cano can kick his PED problems and focus on building his body and increasing his stamina the right way.